WDNA holdings: all 80 positions
WDNA held 80 positions as of Jun 30, 2026. Twist Bioscience Corp is the largest at 5.95%; the top 10 are 30.7% of the fund.
Every position
| # | Holding | Ticker | Weight ↓ |
|---|---|---|---|
| 1 | Twist Bioscience Corp | TWST | 5.95% |
| 2 | Moderna Inc | MRNA | 4.14% |
| 3 | Eli Lilly & Co | LLY | 4.08% |
| 4 | Johnson & Johnson | JNJ | 2.97% |
| 5 | United Therapeutics Corp | UTHR | 2.45% |
| 6 | Natera Inc | NTRA | 2.32% |
| 7 | Tempus AI Inc | TEM | 2.28% |
| 8 | Immunome Inc | IMNM | 2.26% |
| 9 | Structure Therapeutics Inc | GPCR | 2.12% |
| 10 | Stoke Therapeutics Inc | STOK | 2.09% |
| 11 | Beam Therapeutics Inc | BEAM | 2.09% |
| 12 | Corteva Inc | CTVA | 1.99% |
| 13 | Krystal Biotech Inc | KRYS | 1.96% |
| 14 | Darling Ingredients Inc | DAR | 1.94% |
| 15 | Ionis Pharmaceuticals Inc | IONS | 1.86% |
| 16 | Astrazeneca PLC | AZN | 1.83% |
| 17 | 10X Genomics Inc | TXG | 1.81% |
| 18 | Crispr Therapeutics AG | CRSP | 1.77% |
| 19 | Roivant Sciences Ltd | ROIV | 1.73% |
| 20 | Absci Corp | ABSI | 1.71% |
| 21 | Revolution Medicines Inc | RVMD | 1.69% |
| 22 | Agios Pharmaceuticals Inc | AGIO | 1.57% |
| 23 | Amgen Inc | AMGN | 1.54% |
| 24 | Bayer AG | BAYN | 1.53% |
| 25 | Thermo Fisher Scientific Inc | TMO | 1.52% |
| 26 | Gilead Sciences Inc | GILD | 1.51% |
| 27 | Bunge Global SA | BG | 1.51% |
| 28 | Arrowhead Pharmaceuticals Inc | ARWR | 1.47% |
| 29 | Veracyte Inc | VCYT | 1.46% |
| 30 | Biohaven Ltd | BHVN | 1.37% |
| 31 | Novonesis A/S | NSISB | 1.37% |
| 32 | Pfizer Inc | PFE | 1.34% |
| 33 | Vertex Pharmaceuticals Inc | VRTX | 1.34% |
| 34 | Novartis AG | NOVN | 1.33% |
| 35 | Uniqure NV | QURE | 1.23% |
| 36 | Catalyst Pharmaceuticals Inc | CPRX | 1.07% |
| 37 | Exelixis Inc | EXEL | 1.04% |
| 38 | Cullinan Therapeutics Inc | CGEM | 1.04% |
| 39 | Protagonist Therapeutics Inc | PTGX | 1.03% |
| 40 | Dyne Therapeutics Inc | DYN | 1.00% |
| 41 | Celldex Therapeutics Inc | CLDX | 0.96% |
| 42 | Editas Medicine Inc | EDIT | 0.95% |
| 43 | Argenx SE | ARGX | 0.94% |
| 44 | Viking Therapeutics Inc | VKTX | 0.93% |
| 45 | REGENXBIO Inc | RGNX | 0.93% |
| 46 | CG oncology Inc | CGON | 0.90% |
| 47 | BioNTech SE | BNTX | 0.88% |
| 48 | Biogen Inc | BIIB | 0.82% |
| 49 | Allogene Therapeutics Inc | ALLO | 0.82% |
| 50 | Iovance Biotherapeutics Inc | IOVA | 0.77% |
| 51 | Danaher Corp | DHR | 0.75% |
| 52 | Repligen Corp | RGEN | 0.72% |
| 53 | Merck & Co Inc | MRK | 0.70% |
| 54 | Sana Biotechnology Inc | SANA | 0.67% |
| 55 | Verbio Vereinigte Bioenergie SE | VBK | 0.66% |
| 56 | Halozyme Therapeutics Inc | HALO | 0.65% |
| 57 | Ultragenyx Pharmaceutical Inc | RARE | 0.60% |
| 58 | Syensqo SA/NV | SYENS | 0.59% |
| 59 | FMC Corp | FMC | 0.58% |
| 60 | Insmed Inc | INSM | 0.58% |
| 61 | Green Plains Inc | GPRE | 0.58% |
| 62 | Arcturus Therapeutics Holdings Inc | ARCT | 0.55% |
| 63 | Illumina Inc | ILMN | 0.54% |
| 64 | Regeneron Pharmaceuticals Inc | REGN | 0.54% |
| 65 | Intellia Therapeutics Inc | NTLA | 0.53% |
| 66 | Nufarm Ltd | NUF | 0.50% |
| 67 | Bio-Techne Corp | TECH | 0.49% |
| 68 | Bridgebio Pharma Inc | BBIO | 0.48% |
| 69 | BioMarin Pharmaceutical Inc | BMRN | 0.44% |
| 70 | Genmab A/S | GMAB | 0.42% |
| 71 | Oxford Nanopore Technologies PLC | ONT | 0.40% |
| 72 | Zoetis Inc | ZTS | 0.36% |
| 73 | Genus PLC | GNS | 0.34% |
| 74 | Geron Corp | GERN | 0.33% |
| 75 | Tyson Foods Inc | TSN | 0.29% |
| 76 | Rocket Pharmaceuticals Inc | RCKT | 0.29% |
| 77 | Alnylam Pharmaceuticals Inc | ALNY | 0.29% |
| 78 | Sarepta Therapeutics Inc | SRPT | 0.28% |
| 79 | Pacific Biosciences of Califor | PACB | 0.27% |
| 80 | Qiagen NV | QGEN | 0.25% |
| Cash and other net assets | 0.13% |
The book
By country
Share of the fund, positions only, as the fund’s SEC filing states them.
What this list is
How the list is built
Each weight is the share of net assets the fund’s SEC filing gives, largest first. Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract. Where a source leaves out a ticker, ETFIQ fills it from the same security in another fund’s book; names are set in title case where the source used capitals. How books are read.
Weights are as the source states them, largest first.
ETFIQ links to the documents behind every figure; a link is not an endorsement. ETFIQ is an independent publisher and makes no recommendations; every figure is calculated from published data. Standards and sources →
Cite this pageCitation, APA and Markdown
ETFIQ, Holdings of WDNA, data as of Jun 30, 2026. https://etfiq.com/funds/wdna/holdings/
ETFIQ. (Jun 30, 2026). Holdings of WDNA. Retrieved from https://etfiq.com/funds/wdna/holdings/
[Holdings of WDNA (ETFIQ, Jun 30, 2026)](https://etfiq.com/funds/wdna/holdings/)
Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.